Search Results - "melanoma"
Suggested Topics within your search.
Suggested Topics within your search.
- Melanoma 9
- therapy 6
- Antibodies, Monoclonal 4
- Immunotherapy 4
- Neoplasms 4
- immunology 4
- therapeutic use 4
- Antineoplastic Agents 3
- Cancer 3
- methods 3
- Antineoplastic agents 2
- Immunological aspects 2
- Signal Transduction 2
- drug therapy 2
- metabolism 2
- pathology 2
- ACA-28 cpd 1
- Adjuvants, Immunologic 1
- Adoptive Transfer 1
- Amyloid 1
- Antigen Presentation 1
- Antigens, Viral 1
- Antiviral Agents 1
- Astrocytoma 1
- Breast 1
- Breast Neoplasms 1
- CD8-Positive T-Lymphocytes 1
- CTLA-4 Antigen 1
- Cancer Vaccines 1
- Cancer vaccines 1
-
1
Disorders of pigmentation melanoma /
Published 2014Table of Contents: “…Contents: Melanocyte development -- Key factors regulating lineage development -- Relationships to pigmentation diseases -- MITF -- IV-induced pigmentation -- Melanoma-genesis -- Melanoma oncogene discovery -- BRAF-targeted therapy -- Immunotherapy -- Red pigment and melanoma-genesis.…”
Get full text
Series
Electronic Video -
2
RAS and RAF signaling in melanoma biology and therapies /
Published 2010Table of Contents: “…Contents: Melanoma -- BRAF and RAS mutated in approximately 70% of cases -- Mouse models of melanoma -- Oncogenic BRAF can be a founder mutation in melanoma -- Mouse models replicate human disease -- BRAF inhibitors induce paradoxical activation of CRAF and drive pathway activation -- Kinase-dead BRAF mimics this and potentiates RAS ooncogenesis -- BRAF inhibitors induce excellent responses in patients, but may induce mechanism-based side effects through CRAF.…”
Get full text
Series
Electronic Video -
3
Update on therapies for metastatic melanoma
Published 2013Table of Contents: “…Contents: Overview of new treatments approved for advanced melanoma in the past few years -- Pegylated interferon alfa-2b -- Ipilimumab -- Mechanism of action -- Impact on progression-free and overall survival -- Overview of immune-related adverse events -- Vemurafenib -- Mechanism of action -- Impact on progression-free and overall survival -- Induction of secondary squamous cell carcinomas -- Possible role for combined RAF/MEK inhibition -- A "standard" approach to treatment of stage IV melanoma.…”
Get full text
Electronic Video -
4
Immune checkpoint blockade in melanoma
Published 2017Table of Contents: “…Contents: Checkpoint inhibition in melanoma -- Immunotherapy in the adjuvant setting -- Biomarkers of immune response -- The future of immunotherapy in melanoma -- Targeting release of cancer antigens -- Targeting cancer antigen presentation -- Targeting priming and activation of the immune system -- Targeting trafficking and infiltration of T-cells -- Targeting recognition and killing of cancer cells.…”
Get full text
Series
Electronic Video -
5
Cancer pathology
Published 2020Table of Contents: “…Contents: Cancer pathology -- Histology -- Melanoma -- GI colon cancer -- Breast cancer.…”
Get full text
Series
Electronic Video -
6
Cancer vaccines part 1 of 2 /
Published 2015Table of Contents: “…Contents: The hallmarks of cancer -- Categories of cancer-associated antigens -- Viral & non-viral cancers: vaccine targets -- Immunotherapeutics -- Immunologic reagents approved for cancer therapy -- Clinical outcome based on immune response -- CTL-based therapy -- Virus-specific CTL adoptive transfer therapy -- Immunotherapy for Melanoma.…”
Get full text
Series (Immunotherapy of cancer)
Series (Vaccines)
Electronic Video -
7
The dark side of amyloid PMEL, a natural amyloid in melanosome biogenesis /
Published 2020Subjects: Get full text
Series
Electronic Video -
8
Talimogene laherparepvec first-in-class oncolytic immunotherapy /
Published 2016Table of Contents: “…Contents: Causing tumour cell lysis -- Initiating a specific systemic immune response -- T-VEC as an oncolytic HSV-1 strain -- Assessing cancer immunotherapy through melanoma -- Applicability of oncolytic viral therapy to various cancers.…”
Get full text
Series
Electronic Video -
9
Fundamental principles of positron emission tomography (PET) part 2 of 2 /
Published 2022Table of Contents: “…Contents: Aspects of PET imaging -- Image reconstruction -- Filtered Back Projection -- Iterative reconstruction -- Reconstruction comparison -- Factors affecting scanner sensitivity -- 2D and 3D -- Increase in sensitivity in 3D over 2D -- Disadvantages of 3D imaging: loss of contrast & image quality -- Improved sensitivity -- Quantitative PET performance -- Phantom study -- Motion effects -- Partial volume effect -- PET data acquisition schemes -- Static & dynamic modes -- Gated PET -- Time of flight (TOF) acquisition -- Hybrid scanner: PET/CT imaging -- Rationale of PET/CT -- Types of artifacts -- Current PET/CT scanner status -- Different types of PET/CT scanners -- Radiation exposure -- Available dosimetry tools -- PET applications -- Scanning Melanoma, Lymphoma and Brain Astrocytoma -- Imaging in Neurology: Parkinson's disease -- Receptor binding -- Imaging in Cardiology.…”
Get full text
Series
Electronic Video -
10
A novel cancer therapy to stimulate oncogenic ERK signalling
Published 2018Subjects: Get full text
Series
Electronic Video -
11
Checkpoint blockade in cancer immunotherapy
Published 2007Table of Contents: “…Contents: Activation of naive T-cells -- CD28 and CTLA-4 -- Differential regulation of T-cell responses -- Responding repertoire -- Biological role of CTLA-4 -- Tumor-specific immune responses -- Treg activity -- CTLA-4/GVax -- Immunotherapies -- Conventional therapies -- Ipilumumab -- Clinical studies: melanoma -- Reversible immune mediated toxicity.…”
Get full text
Series
Electronic Video -
12
Understanding hormones mechanisms of androgen receptor function in reproduction and cancer /
Published 2007Table of Contents: “…Contents: Mechanisms of androgen action -- Biological basis for androgen potency -- Androgen receptor FXXLF motif and N/C interaction -- Androgen receptor coactivator melanoma antigen gene protein-11 -- Androgen receptor mutations in the androgen insensitivity syndrome and prostate cancer -- Mechanisms of prostate cancer progression to castration-recurrent disease.…”
Get full text
Series
Electronic Video -
13
Diagnostic immunohistopathology
Published 2007Table of Contents: “…Contents: Techniques for identification and immunocytochemical study of proteins -- Leucocyte-associated molecules -- Immunhistological labeling -- Immunohistological studies of human tissue -- The first monoclonal anti-leucocyte antibodies -- Paraffin reactive monoclonal antibodies -- Protein conformation and antigenicity -- Immunohistological markers for the study of solid tumors -- Carcinoma, seminoma, mesothelioma, melanoma and carcinoid tumors -- Immunohistological markers for the diagnosis of lymphoid neoplasms -- Anaplastic large cell lymphoma -- New labeling techniques -- New antibodies and molecular targets.…”
Get full text
Series
Electronic Video